← Research library

Optimization of the treatment of anxiety disorders with selank

Comparison in people · 2015

What was studied
70 patients: 40 Selank plus phenazepam; 30 phenazepam alone
Main finding
The authors report earlier symptom improvement and fewer unwanted effects with adjunctive Selank. Both groups received phenazepam.

Reported findings and study design

70 patients: phenazepam alone 30 versus phenazepam plus Selank 40.

Population or model 70 patients: 40 Selank plus phenazepam; 30 phenazepam alone

Results · Previously retrieved indexed abstract; numerical statements checked against the saved source text
MeasureResultComparison, timing and statistics
Anxiety improvementEarlier with add-on SelankNo numerical magnitude reported
Sedation and other adverse symptomsFewer reported with the combinationEvent counts not supplied

Both groups received phenazepam. This comparison does not isolate Selank monotherapy.

Source for these results ↗ · Reviewed 2026-10-29

Study limitations and source details

Study limitations

  • Does not isolate Selank monotherapy.
  • Allocation and blinding unresolved; a combination comparison is not general evidence of safety.

Source details

Journal article

Indexed abstract checked; allocation, blinding and full outcome tables not reviewed.

Abstract

Sources checked

Citation

Human comparative studyEnglish abstract

V. E. Medvedev, O. N. Tereshchenko, N. V. Kost, A. Y. Ter-Israelyan, E. V. Gushanskaya, I. K. Chobanu, O. Y. Sokolov, N. F. Myasoedov. Optimization of the treatment of anxiety disorders with selank Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(6):33–40

Study source ↗ · DOI 10.17116/jnevro20151156133-40 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards